MAPK8 and Alzheimer disease: It was found that insulin receptor substrate 1 (IRS-1) inhibition by amyloid β (Aβ) oligomers, a pathological hallmark of AD, via TNF-α/JNK activation showed impaired brain insulin signaling in AD and promoted proinflammatory signaling 17.